The global ovarian cancer diagnostics market size was estimated at USD 1.2 billion in 2018 and is expected to grow at a CAGR of 6.2% during the forecast period. Rising prevalence of ovarian cancer and increasing emphasis on early diagnosis & treatment are expected to drive market gro...Read More »
July : 2019The global neurological biomarkers market is projected to exhibit strong growth through the forecast period, driven by an increasing global burden of neurological diseases and technological advancements. Proactive government initiatives and steady growth in consumer awareness are likely ...Read More »
The global anatomic pathology market size was estimated at USD 15.4 billion in 2018 and is expected to register a CAGR of 6.1% over the forecast period. Increase in clinical use of biomarkers enables pathologists to determine disease pathogenesis at a molecular level and guides in clinic...Read More »
July : 2019The global malaria diagnostics market size was valued at USD 661.24 million in 2018 and is anticipated to witness a CAGR of 5.4% during the forecast period. Rising demand for malaria diagnostics and introduction of novel diagnostic techniques are the key factors driving the market. Malar...Read More »
June : 2019The global predictive genetic testing & consumer/wellness genomics market size was estimated at USD 3.4 billion in 2018 and is anticipated to exhibit a CAGR of 13.9% over the forecast period. Broadening horizon of predictive genetic testing as a consequence of increase in number of p...Read More »
June : 2019The global sperm bank market size was estimated at USD 4.33 billion in 2018 and is projected to expand at a CAGR of 3.3% over the forecast period. Innovations in cryopreservation techniques, rising awareness, emergence of fertility tourism, and increasing access to infertility treatment ...Read More »
May : 2019The global sepsis diagnostics market size was valued at over USD 502.0 million in 2018 and is expected to witness a CAGR of 9.8% over the forecast period. Rising prevalence of sepsis has led to a growing need for its early diagnosis. Septic poisoning may result in severe inflammation, le...Read More »
May : 2019The global point-of-care molecular diagnostics market size was valued at USD 1.72 billion in 2018 and is anticipated to expand at a CAGR of 14.4% over the forecast period. Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the...Read More »
May : 2019The global blood culture tests market size was valued at over USD 3.7 billion in 2018 and is anticipated to expand at a CAGR of 9.1% over the forecast period. Growing approval rate of new products, such as instruments and consumables for Bloodstream Infections (BSI) diagnosis, by regulat...Read More »
April : 2019The global blood preparation market size was valued at USD 36.7 billion in 2018and is projected to expand at a CAGR of 5.6% from 2019 to 2026. Growing demand for blood and its components in surgical procedures is expected to be a key factor driving the market. According to the Healthcare...Read More »
April : 2019The global In Vitro Diagnostics market size was valued at USD 69.6 billion in 2018 and is estimated to register a CAGR of 4.75% from 2019 to 2026. Growing geriatric population, which is susceptible to various diseases and requires regular diagnostic tests, is expected to be one of the hi...Read More »
April : 2019The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to d...Read More »
April : 2019The global clinical laboratory services market size was estimated at USD 212.18 billion in 2018 and is projected to grow at a CAGR of 6.4% during the forecast period. Such services help deliver effective care in the current complex healthcare system. Quality clinical lab services encompa...Read More »
April : 2019The global molecular diagnostics market size was valued at USD 9.9 billion in 2018 and is anticipated to expand at a CAGR of 9.1% over the forecast period. Advancements in molecular diagnostics have enabled detection of various diseases that could possibly reduce social and economic burd...Read More »
April : 2019The global Preimplantation Genetic Testing (PGT) (PGS/PGD) market size was estimated at USD 74.72 million in 2018 and is expected to expand at a CAGR of 6.2% over the forecast period. Recent technological advancements have profoundly changed thecurrent practice of prenatal screening and ...Read More »
April : 2019The global biomarkers market size was valued at USD 40.8 billion in 2018 and is expected to expand at a CAGR of 13.7% over the forecast period. Technological advancements in development of biomarker-based diagnostics are likely to contribute to the expansion of the market. Increase ...Read More »
April : 2019The global point of care diagnostics/testing market was valued at USD 18.09 billion in 2018 and is expected to register a CAGR of 3.3% over the forecast period. Continuous developments in R&D activities to miniaturize molecular and professional diagnostic tests is anticipated to driv...Read More »
March : 2019The global histology and cytology market size was valued at USD 11.0 billion in 2018 and is estimated to expand at a CAGR of around 13.7% over the forecast period. High prevalence of cancer and continuous R&D are expected to be the key factors driving the growth. Technological advanc...Read More »
March : 2019The global In Vitro Diagnostics quality control market size was valued at USD 905 million in 2018 and is anticipated to register a CAGR of 4.1% over the forecast period. Increasing number of accredited clinical laboratories worldwide and presence of favorable regulatory bodies are expect...Read More »
March : 2019The global IVD infectious diseases market size was valued at USD 18.8 billion in 2018. It is likely to exhibit a CAGR of 6.7% from 2018 to 2026. Increasing external funding for research and development (R&D) activities and proactive government initiatives are among the primary growth...Read More »
March : 2019The global clinical laboratory tests market size was valued at USD 165.48 billion in 2018. It is expected to expand at a CAGR of 7.1% during the forecast period. Rise in prevalence of chronic disorders along with heightened awareness among health-conscious people has encouraged the growt...Read More »
February : 2019The global cancer diagnostics market size was valued at USD 144. 4 billion in 2018 and is expected to register a CAGR of 7.0% over the forecast period. Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening...Read More »
February : 2019The global rabies diagnostics market size was valued at USD 1.47 billion in 2017 and is projected to expand at a CAGR of 4.1% during the forecast period. Neglected Tropical Diseases (NTDs) have afflicted several densely populated and low-resource setting regions across the globe. One suc...Read More »
February : 2019The global tissue diagnostics market size was estimated at USD 3.9 billion in 2018 andis poised to exhibit a CAGR of 6.6% during the forecast period. Increase in worldwide volume of diagnostic tests conducted across hospitals and laboratories has boosted the market. Future growth prospec...Read More »
January : 2019The global antiseptics and disinfectants market size was valued at USD 16.75 billion in 2018 and is expected to expand at a CAGR of 6.7% over the forecast period. High prevalence of Hospital-acquired Infections (HAIs), awareness about home hygiene and the need for disinfection, and incre...Read More »
January : 2019The global hematology diagnostics market size was estimated at USD 5.96 billion in 2017. It is anticipated to expand at a CAGR of 5.85% over the forecast period. The factors such as increasing prevalence of blood disorders coupled with increasing awareness about these disorders, and pres...Read More »
December : 2018The global capillary blood collection devices market size was valued at USD 1.15 billion in 2017. It is projected to expand at a CAGR of 5.4% during the forecast period. Rising availability of PoC diagnostics, increasing prevalence of chronic diseases, and various advantages of the produ...Read More »
December : 2018The global contrast media/contrast agents market size was valued at USD 4.89 billion in 2017 and is anticipated to grow at a CAGR of 3.5% during the forecast period. This growth is attributed to the nature of this space, which exhibits an oligopolistic structure with key companies ...Read More »
November : 2018Creatinine is an endogenous by-product of muscle metabolism. Clinical laboratory measurement of this waste product is used for the assessment of glomerular filtration rate (GFR) that further defines kidney function of patient. Most of the routine creatinine assays that are in current use...Read More »
The global breast lesion localization methods market size was valued at USD 580.7 Million in 2017 and is projected to expand further at a CAGR of 13.3% during the forecast period. Breast cancer is the most prominent and invasive cancers; thus, increasing prevalence of it among women is e...Read More »
November : 2018The North American molecular diagnostics market size was USD 3.66 billion in 2017 and is expected to register a CAGR of 10.4% over the forecast period. Increased adoption of molecular diagnostics (MDx) for infectious diseases, coupled with advent of new cancer diagnostic solutions, is dr...Read More »
November : 2018The global antinuclear antibody test market size was valued at USD 923.1 million in 2017. It is projected to expand at a CAGR of 12.5% over the forecast period. High prevalence of autoimmune disorders coupled with awareness regarding these diseases is likely to drive the market over the ...Read More »
October : 2018The global disruptive behavior disorder (DBD) treatment market size was valued at USD 15.7 billion in 2017 and is expected to register a CAGR of 4.9% over the forecast period. The market is mainly driven by the growing prevalence of behavioral disorders. Disruptive behavior or externaliz...Read More »
October : 2018The global colposcopy market size was valued at USD 171.5 million in 2017. It is anticipated to exhibit a CAGR of 7.0% during the forecast period. Rising prevalence of cervical cancer and high demand for early diagnostic techniques are among the key growth stimulants for the market. Ther...Read More »
October : 2018The global women’s health diagnostics market size was valued at around USD 43.5 billion in 2017. It is expected to expand at a CAGR of 7.3% during the forecast period. Rising prevalence of infectious diseases, such as hepatitis and urinary tract infection, among women is anticipate...Read More »
September : 2018The U.S. sterilization services market size was valued at USD 1.83 billion in 2017. Rise in prevalence of chronic diseases and various initiatives taken by the government to ensure adoption of essential sterilization standards in hospitals and research centers is expected to drive the ma...Read More »
September : 2018Increase in collaborations between key diagnostics manufacturers and pharmaceutical companies for the development of effective solutions to circumvent cancer management related challenges is driving the oncology companion diagnostics market. For instance, in January 2016, NanoString Tech...Read More »
Neuroendocrine carcinoma market is expected to witness lucrative growth over the forecast period due to increase in incidence of neuroendocrine tumors (NETs) around the globe. This type of cancer occurs in the neuroendocrine system of human body and produce hormones similar to neuroendoc...Read More »
The global immunohistochemistry (IHC) market size was valued at USD 1.6 billion in 2017. It is projected to expand at a CAGR of 8.8%in terms of revenue over the forecast period. Immunohistochemistry (IHC), as a crucial application of monoclonal and polyclonal antibodies helps unders...Read More »
August : 2018The global pharmaceutical sterility testing market size was valued USD 733.7 Million in 2016. It is estimated to register a CAGR of 11.8% over the forecast period. Government investments in the healthcare industry, increasing R&D activities and number of drug launches, and risin...Read More »
August : 2018The North America and Europe stroke diagnostics market size was valued at USD 1.46 billion in 2016. It is anticipated to witness a CAGR of 6.2% during the forecast period. Stroke is considered as one of the leading causes of mortality and physical disability in North America and Europe. ...Read More »
July : 2018The U.S. pharmaceutical sterility testing market size was estimated at USD 302.2 million in 2017. It is expected to register a CAGR of 11.3% over the forecast period. Increase in R&D activities and in number of product approvals is anticipated to boost the market growth. In addition,...Read More »
July : 2018The global transplant diagnostics market size was valued at USD 500.1 million in 2016 and is likely to expand at a CAGR of 7.6% over the forecast period. Increasing organ transplants is a major factor driving demand for diagnostics used before the procedure. Demand for transplants h...Read More »
June : 2018The global clinical microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising incidence of infectious diseases is driving market growth. Infectious diseases are primarily diagnosed using clinica...Read More »
June : 2018The global assisted reproductive technology market size was estimated to be around USD 21 billion in 2017 and is anticipated to grow at a CAGR of 10% over the forecast period. Contributing factors to the growth are the increasing number of infertility cases due to obesity, growing stress...Read More »
May : 2018The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising prevalence of hepatitis diagnostics is primarily diving the growth of the global market. A data published by the World Health ...Read More »
May : 2018The global blood screening market size was valued at USD 1.6 billion in 2015 and is projected to grow at a CAGR of 10.2% over the forecast period. Blood screening is a process in which donated blood is screened for various infectious diseases such as HBV, HCV, HIV1, and HIV2. High growth...Read More »
April : 2018The global zika virus Testing market size was valued at USD 131.9 million in 2016. It is projected to exhibit a CAGR of 7.6% over the forecast period. Involvement of international organizations, such as UNICEF, and national governments in low-income developing regions is one of the key t...Read More »
April : 2018The global non-invasive prenatal testing market size was estimated at USD 1.19 billion in 2015. Advantages associated with the use of these tests such as leading to significant reduction in the number of expensive and risky invasive amniocentesis and Chorionic Villus Sampling (CVS) proce...Read More »
March : 2018The global C-reactive protein test market size was estimated at USD 1.57 billion in 2016 and anticipated to expand at a CAGR of 1.3% over the forecast period. It is driven by high R&D in the field of C-reactive protein (CRP) testing and rising burden of various chronic and inflammato...Read More »
March : 2018The global influenza diagnostics market size was valued at USD 1.91 billion in 2015 and is anticipated to witness a CAGR of 6.4% during the forecast period. Influenza, which is commonly called the flu is an infectious disease of the upper respiratory system caused by the influenza virus....Read More »
March : 2018The global blood testing market size was estimated at USD 51.5 billion in 2015. Confluence of influencing factors, such as accelerated disease R&D, rising prevalence of chronic disease, and consumerism; is anticipated to augment the scope of blood testing services throughout the fore...Read More »
March : 2018The global endocrine testing market size was valued at USD 7.04 billion in 2016 and is expected to witness a CAGR of 8.0% over the forecast period. Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine t...Read More »
March : 2018The global primary care POC diagnostics market size was estimated at USD 6.3 billion in 2016.Rapid evolution of point-of-care testing (POCT) holds enormous potential for the growth of both primary and secondary care settings. Rapidly increasing healthcare expenditure within secondary and...Read More »
March : 2018The global newborn screening market size was valued at USD 783.5 million in 2016 and is expected grow at a CAGR of 10.6% during the forecast period. Growing neonatal population base, rising cases of congenital diseases in newborns, favorable government programs & legislations, and te...Read More »
February : 2018The Latin America clinical laboratory services market size was estimated at USD 14.4 billion in 2016 and is projected to expand at a CAGR of 7.5% over the forecast period. Rising burden of chronic diseases, coupled with consequent demand for diagnostic tests, is expected to serve as a hi...Read More »
February : 2018The global neglected tropical diseases diagnosis market size was estimated at USD 5.3 billion in 2016. Formal recognition of Neglected Tropical Diseases (NTDs) in the sustainable development goals as a global target is expected to drive market growth. In the past, NTDs did not receive th...Read More »
February : 2018The global drug of abuse testing services market size was estimated at USD 1,465.4 million in 2016. Increase in the number of disorders associated with overuse of illicit substance and enforcement of legislations for Alcohol and Drug (A&D) testing are some of the key factors anticipa...Read More »
December : 2017The global stethoscope market size was valued at USD 327.7 million in 2016 and is expected to grow at a CAGR of 4.7% over the forecast period. The global rise in cardiovascular and pulmonary diseases, increasing healthcare expenditure, and technological advancements such as Bluetooth con...Read More »
November : 2017The global hematologic malignancies market size was valued at USD 35.6 billion in the year 2016 with a CAGR of 10.48%. Growing incidence of blood cancer and increasing focus on development of new treatments are expected to drive the growth. Globally, blood malignancies are the fifth most...Read More »
September : 2017The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at USD 1.6 billion in 2016. Increasing demand for INAAT as a molecular testing technique and rising prevalence of infectious diseases are expected to drive the market over the forecast period. Acco...Read More »
August : 2017The global point of care infectious disease diagnostics/testing market size was estimated at USD 1.05 billion in 2016. Driven by latest trends of consumer centric services coupled with high demand for portable and rapid testing devices this market is expected to witness lucrative growth....Read More »
August : 2017The global Structural Heart Imaging (SHI) market size was estimated at USD 10.1 billion in 2016. Global increase in incidence of Congenital Heart Diseases (CHDs) and rising government support to improve accessibility to treatments are expected to be major factors driving growth. CHDs rep...Read More »
August : 2017The global NASH (Non-alcoholic Steatohepatitis) biomarkers market size was valued at USD 200.04 million in 2016 and is expected to witness a CAGR of 30.1% during the forecast period. Growing prevalence of chronic liver conditions is expected to upsurge demand for noninvasive diagnostic t...Read More »
July : 2017The global pharmacogenomics technology/theranostics/ CDx market size was estimated at USD 5.62 billion in 2016. Theranostics, are pioneering personalized medicine by predicting prognosis, and pinpointing diagnoses down to the subtype of chronic conditions. Rising cost of healthcare coupl...Read More »
June : 2017The global vitamin D testing market size was estimated at USD 498.1 million in 2016. Global rise in geriatric population coupled with increase in chronic illnesses, such as type 2 diabetes, kidney disease, Crohn's disease, and celiac disease, is anticipated to drive the growth of the mar...Read More »
May : 2017The global biopsy devices market size was estimated at USD 1.0 billion in 2016. Growing prevalence of cancer worldwide and presence of untapped opportunities in emerging economies, especially of Asia Pacific, along with improving healthcare infrastructure in these regions are among the k...Read More »
May : 2017The global kidney function tests market size was valued at USD 1.2 billion in 2016 and is expected to grow at a CAGR of 5.2% over the forecast period. The growing prevalence of chronic kidney diseases is presumed to be responsible for growth attained by this market. The high prevalence i...Read More »
March : 2017The global nucleic acid amplification testing (NAAT) market size was valued at USD 1.78 billion in 2015. Growing demand for the advanced diagnostic measures and increasing investments for development of new biotechnological diagnostic techniques are the key factors propelling the growth ...Read More »
February : 2017The global blood collection market size was valued at USD 7.6 billion in 2015 and is projected to grow at 6.1% over the forecast period. Increasing prevalence ofinfectious and non-communicable diseases, mounting number of accident & trauma cases are the major factors contributing tow...Read More »
February : 2017The global Autoimmune Disease Diagnostics Market disease diagnostics market size was valued at USD 3.3 billion in the year 2015 and is estimated to reach a value of USD 5.0 billion by 2025, growing with CAGR of 4.1%. Increasing prevalence of autoimmune disorders such as type 1 diabetes i...Read More »
February : 2017The global legionella testing market size was valued at USD 160.0 million in 2015 and is expected to grow at a CAGR of 8.4% during forecast period. The increasing incidence of Legionella-related disorders and rising awareness about their preventive management is expected to drive the mar...Read More »
January : 2017Atrial septal defect (ASD) is a congenital heart defect in which blood flows between the atria of the heart chamber. Normally, the artria are separated by a dividing wall, the interatrial septum. If this septum is defective or absent then oxygen rich blood can flow directly from the left...Read More »
Arrhythmia is an abnormal heart rhythm. It may feel like fluttering or a brief pause. It may be so brief that it does not change your overall heart rate (the number of times per minute that your heart beats); or it can cause the heart rate to be too slow or too fast. Some arrhythmia&rsqu...Read More »
The U.S. IVD and LDT for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach USD 4.74 billion by 2024. The market growth can be attributed to rising occurrence of autoimmune diseases & cancers and technological advances in diagnostic techniques. ...Read More »
November : 2016Lymphoma is a medical term for blood cancer. Development of lymphoma indicates abnormal growth of B or T lymphocytes and also if these cells survive longer than their normal cycle. Lymphoma is generally found in bone marrow, spleen, and other parts that constitute the lymphatic syst...Read More »
Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and ...Read More »
The global cervical cancer diagnostic market was valued at USD 7 billion in 2015 and is projected to grow at a CAGR of 5.9% over the forecast period. Women between the age group of 20 and 60 years are usually more prone to this ailment, which is expected to increase the screening and dia...Read More »
September : 2016The global tuberculosis diagnostics market was valued at USD 2.1billion in 2015 and is expected to witness a CAGR of 4.1% over the forecast period.The rising burden of tuberculosis is one of the biggest concerns among the government and healthcare agencies....Read More »
September : 2016The cardiac biomarkers market was estimated to reach USD 4.7 billion in 2015. Cardiac biomarkers refer to the substances released in the bloodstream due to heart-related damage or stress, mainly caused by insufficient blood flow. The quantification of biomarkers is employed for the diagn...Read More »
September : 2016The Europe molecular diagnostics market size was valued at USD 1,750.0 million in 2015 and is expected to exhibit attractive growth over the forecast period. As a developed region, technology enhancement is enabling the European market to further grow through the development of new produ...Read More »
August : 2016The Europe IVD market was valued at USD 12.51 billion in 2015. The growing base of the geriatric population in the European countries, the increasing prevalence of chronic diseases, and the rising awareness among the population for early diagnosis of life-threatening diseases are the hig...Read More »
August : 2016The global critical care diagnostic (CCD) market size was estimated at USD 837.6 million in 2015. These diagnostic tests deal with the specialized care and diagnosis of life-threatening diseases occurring in patients....Read More »
August : 2016North America point of care diagnostics market was valued at USD 6.84 billion in 2015. Growing awareness for home healthcare coupled with rapid and cost-effective results provided by POC diagnostics is anticipated to propel market growth. ...Read More »
August : 2016Latin America point of care diagnostics market size was valued at USD 1.19 billion in 2015. Hospitals, assisted living homecare facilities and other healthcare facilities are noted to have increased adoption rates of POC diagnostics in Latin America to provide rapid and effective diagnos...Read More »
August : 2016The Asia Pacific In Vitro Diagnostics (IVD) market was estimated at USD 12.1 billion in 2015. The increase in number of infectious and chronic diseases, the rising awareness levels of advanced diagnostic solutions as well as technological developments are estimated to be some major facto...Read More »
August : 2016The global Computer Aided Detection (CAD) market size was valued at USD 405.9 million in 2014. Increasing cancer prevalence and rising awareness in the population for regular health check-ups are the most significant drivers of the global CAD industry....Read More »
August : 2016The global Human Papillomavirus (HPV) testing and Papanicolaou test (Pap test) market size was valued at over USD 3,200 million in 2015. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. The causative agent of cervical cancer is a sexua...Read More »
June : 2016The global lung cancer diagnostics market size was estimated at USD 1.63 billion in 2015.Technological advancements pertaining to tumor diagnosis contribute towards the market growth. The need for more efficient diagnostic systems is due to the fact that only 15% of the lung cancer cases...Read More »
June : 2016The global in-vitro colorectal cancer screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period....Read More »
June : 2016The global urinalysis market size was estimated at USD 1.37 billion in 2015.The magnitude of the target diseases, such as UTI, kidney diseases, and diabetes, is immense with the occurrence of millions of new cases every year. Urinalysis is used as the primary diagnostic tool for the diag...Read More »
April : 2016Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response. Most chronic pain is caused by the illness and most acute pain is caused by t...Read More »
If blood cell counts are low, then the drug given by the doctor is termedas a blood cell growth factor to stimulate the blood cell production. The body normally makes blood cell with the help of a hormone produced in the kidneys, called erythropoietin (EPO). The DNA of immature bloo...Read More »
The global glucose biosensor market was estimated at USD 15.3 billion in 2015. Increasing incidence of diabetes across the globe is expected to be a key factor driving market growth....Read More »
February : 2016The European Real-time Polymerase Chain Reaction (qPCR) market was valued at over USD 182 million in 2014....Read More »
February : 2016Global STD diagnostics market size was valued at over USD 17 billion in 2014. Increase in patient awareness such as education campaigns and growing government initiatives are anticipated to drive market growth. ...Read More »
January : 2016The global HIV diagnostics market was valued at USD 2,173.8 million in 2014 and is expected to grow at a CAGR of 9.5% over the forecast period....Read More »
January : 2016The Europe, Middle East, and Africa (EMEA) Point-of-Care (PoC) diagnostics market size was valued at USD 4,567.2 million in 2014. Growing base of geriatric population coupled with high incidence rates of chronic diseases is one of the major factors fostering the growth of EMEA PoC diagno...Read More »
January : 2016The heart attack diagnostics market was estimated to reach USD 6.6 billion in 2015. Heart attack or myocardial infarction is a form of cardiovascular disease (CVD) and it occurs when oxygenated blood flow to the heart muscle is reduced or cut off, which is also termed as myocardial ische...Read More »
July : 2015Automated microbiology market is expected to grow over the forecast period owing to the increasing prevalence of pathogen induced diseases. In the recent years, identification of pathogens with the help of automated microbiology has generated huge momentum, as it helps in early detection...Read More »
Rising incidences of genetic disorders that give rise to wide variety of independent diagnostic procedures globally is predominantly driving the growth of the global genetic disorder diagnostic market. Additionally, increasing awareness about prenatal diagnosis, rising attempt to improve...Read More »
Infectious disease diagnostic market is expected to grow during the forecast period owing to the increasing prevalence of various infectious diseases such as, malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs and diarrheal diseases. The other vital drivers of this market are growing demand of...Read More »
The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of sedentary lifestyle...Read More »
Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving the asthma and chronic obstructive pulmonary disease (COPD) market globally. Asthma & COPD are chronic respiratory diseases ...Read More »
Companion diagnostics is a form of In Vitro Diagnostics which provides healthcare practitioners with the information about the patient’s response to a particular treatment. ...Read More »
The rising prevalence of cardiovascular and pulmonary disorders such as arrhythmia and heart valve imbalance are the major factors driving the cardiopulmonary stress testing systems. Furthermore, increasing incidences of lifestyle diseases coupled with heart and lung disorders are the fa...Read More »
Growing prevalence of cancer and other rare life threatening disorders such as HIV, increased research and development, cost effectiveness of genomic sequences are the growth propellers for bioinformatics in vitro diagnosis (IVD) market. ...Read More »
Tuberculosis is an infectious or sometimes fatal disease with mycobacteria its major cause. In common tuberculosis attacks the lungs, or even other parts of the body such as genitourinary system, lymphatic system and central nervous system. ...Read More »
Point of care (POC) diagnosis refers to conducting diagnostic tests near the site of patient care. The Asia Pacific PoC diagnostics market is driven by four major factors namely growing geriatric population base in countries such as Japan and China, rising prevalence of target diseases, ...Read More »
April : 2014Cancer or malignant neoplasm refers to a group of diseases caused by abnormal cell growth. This disease is marked by uncontrollable cell growth forming malignant tumors which invade surrounding body parts. Some of the major types of cancer (based on prevalence as of 2008) are lung, stoma...Read More »
The endocrine system consists of a group of glands which produce and release hormones for the appropriate functioning of body functions. The most important function of these glands is to assist the body to change calories into energy to power cells and organs. These glands also play an i...Read More »
Yerinia is a gram positive rod shaped bacteria belonging to the Enterobacteriaceae family. Pathogenic species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis. The Yersinia pestis specie of this bacterium causes Bubonic plague and is carried by...Read More »
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer....Read More »
Rapid medical diagnosis refers to quick diagnostic tests (deliver results in less than two hours) performed without the use of automated diagnostic equipment. The growing prevalence of cardiovascular diseases, sexually transmitted diseases, diabetes, infectious diseases, hepatitis and ga...Read More »
Global orthopedic extremity market is expected to witness lucrative growth over the forecast period owing to rising global geriatric population base, coupled with increasing life expectancy rate. Rise in incidence rate of sports injuries, prevalence of obesity, and other bone related dis...Read More »
Global human papilloma virus testing market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of cervical cancer. Rise in global geriatric female population is also one of the key drivers for market growth due to the presence of co-morbiditie...Read More »
Global diagnostic electrocardiography devices market is expected to witness lucrative growth over the forecast period owing to increasing prevalenceof cardiovascular diseases coupled with rising geriatric population base. Hence, the need of innovation in diagnostics for detection of dise...Read More »
The global scenario for the dental diagnostic and surgical equipment market is expected to boost over the forecast period. Rising inclination towards junk food consumption and improper eating habits by individuals along with augmenting demand for cosmetic dentistry are considered to be t...Read More »